Turtle Creek Wealth Advisors LLC Increases Stake in Aflac Incorporated (NYSE:AFL)

Turtle Creek Wealth Advisors LLC grew its holdings in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 4.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 60,595 shares of the financial services provider's stock after purchasing an additional 2,561 shares during the quarter. Turtle Creek Wealth Advisors LLC's holdings in Aflac were worth $6,738,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the business. Valued Wealth Advisors LLC increased its position in shares of Aflac by 24.4% during the 1st quarter. Valued Wealth Advisors LLC now owns 495 shares of the financial services provider's stock valued at $55,000 after purchasing an additional 97 shares during the last quarter. Phillips Wealth Planners LLC increased its holdings in Aflac by 1.5% in the 1st quarter. Phillips Wealth Planners LLC now owns 6,653 shares of the financial services provider's stock worth $711,000 after acquiring an additional 100 shares during the last quarter. Optas LLC increased its holdings in Aflac by 3.5% in the 1st quarter. Optas LLC now owns 2,949 shares of the financial services provider's stock worth $328,000 after acquiring an additional 101 shares during the last quarter. Family Legacy Inc. increased its holdings in Aflac by 4.3% in the 4th quarter. Family Legacy Inc. now owns 2,607 shares of the financial services provider's stock worth $270,000 after acquiring an additional 107 shares during the last quarter. Finally, Titleist Asset Management LLC increased its holdings in Aflac by 3.4% in the 4th quarter. Titleist Asset Management LLC now owns 3,324 shares of the financial services provider's stock worth $344,000 after acquiring an additional 110 shares during the last quarter. 67.44% of the stock is owned by hedge funds and other institutional investors.

Aflac Price Performance

Shares of AFL traded up $0.03 during trading hours on Thursday, reaching $101.47. 1,955,793 shares of the company's stock traded hands, compared to its average volume of 2,153,529. The stock has a market cap of $54.86 billion, a PE ratio of 15.85, a price-to-earnings-growth ratio of 3.14 and a beta of 0.81. The company has a current ratio of 0.09, a quick ratio of 0.09 and a debt-to-equity ratio of 0.29. The firm's 50 day simple moving average is $103.41 and its 200-day simple moving average is $105.18. Aflac Incorporated has a 12 month low of $92.44 and a 12 month high of $115.50.

Aflac (NYSE:AFL - Get Free Report) last issued its quarterly earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). The business had revenue of $3.40 billion for the quarter, compared to the consensus estimate of $4.53 billion. Aflac had a net margin of 21.27% and a return on equity of 15.55%. The business's revenue was down 37.5% compared to the same quarter last year. During the same quarter last year, the business posted $1.66 EPS. Equities analysts expect that Aflac Incorporated will post 6.88 EPS for the current year.

Aflac Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, June 2nd. Investors of record on Wednesday, May 21st were given a $0.58 dividend. The ex-dividend date of this dividend was Wednesday, May 21st. This represents a $2.32 dividend on an annualized basis and a yield of 2.29%. Aflac's payout ratio is 36.25%.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on AFL shares. Barclays set a $98.00 price objective on Aflac and gave the stock an "underweight" rating in a report on Monday, July 7th. UBS Group lifted their price objective on Aflac from $109.00 to $114.00 and gave the stock a "neutral" rating in a report on Wednesday, April 2nd. Raymond James Financial decreased their price objective on Aflac from $115.00 to $110.00 and set an "outperform" rating for the company in a report on Thursday, May 29th. Piper Sandler lifted their price objective on Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a report on Wednesday, April 2nd. Finally, Wall Street Zen lowered Aflac from a "hold" rating to a "sell" rating in a report on Monday, May 5th. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and three have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $107.07.

Insider Buying and Selling

In related news, Director Masatoshi Koide sold 37,000 shares of the business's stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $105.59, for a total value of $3,906,830.00. Following the completion of the sale, the director owned 70,992 shares in the company, valued at $7,496,045.28. The trade was a 34.26% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Joseph L. Moskowitz sold 1,000 shares of Aflac stock in a transaction that occurred on Thursday, May 8th. The stock was sold at an average price of $106.79, for a total value of $106,790.00. Following the completion of the transaction, the director directly owned 26,096 shares in the company, valued at $2,786,791.84. This trade represents a 3.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 40,750 shares of company stock worth $4,304,295 in the last quarter. 0.90% of the stock is owned by insiders.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.